In addition to neurotransmitters, hormones, acting through the blood stream, also play a role in behavior. To test the potential contribution of genetic variations in hormone receptors we have examined the association between the alleles of the dinucleotide repeat of the estrogen receptor 1 gene (ESR1) and the nine subscores and total score of the SCL-90 in a group of 179 adult males treated for substance abuse. Based on our prior hypothesis that the length of repeat polymorphisms may play a direct role in gene regulation, the alleles were divided into two groups, short (S) and long (L). ANOVA of the SS, LS, and LL genotypes showed a significant association at ␣ Յ0.05 for three of the SCL-90 scores: anxiety, phobic anxiety, and total symptoms. Of these the anxiety score remained significant at a Bonferroni corrected ␣ of Յ0.005. By regression analysis, the ESR1 gene accounted for 7% of the variance of the anxiety score (P Յ 0.0004). These results are consistent with a role of the ESR1 gene in human behavior. Since estrogen levels are much higher in women than men, this could account for the increased frequency of anxiety in women.
Pert
1 (p 139) pointed out that the majority of neurons that release specific neurotransmitters or neuropeptides are not immediately adjacent to the neurons that carry the corresponding receptors. This suggests that many of the most important events in the brain may occur at a distance-as hormones. Estrogen exerts a profound effect on mood and memory through its action on monoamine and neuropeptide transmitter mechanisms in the brain. 2 We previously observed that the alleles of two trinucleotide repeat polymorphisms of the first exon of the androgen receptor gene (AR) are significantly associated with a range of disruptive behavioral disorders. 3 This led us to also examine the estrogen receptor gene (ESR1). Evidence that this gene plays a role in behavior in animals comes from studies showing that ESR1 knockout mice show aggressive behaviors. 4 While variants of the ESR1 gene have been implicated in osteoporosis and osteoarthritis, [5] [6] [7] there have been no prior studies of the role variants of the ESR1 in human behavior. To examine this we have genotyped 179 subjects with substance abuse at a highly polymorphic dinucleotide repeat of the ESR1 gene. 8 The SCL-90 9 was utilized as a screening test for depression, anxiety, and related disorders.
The distribution of the 787 alleles of the ESR1 gene that we have genotyped in our laboratory, for this and other studies, is shown in Figure 1 . There was no significant difference in the frequency of the S vs the L alleles in the three racial groups. Table 1 shows the results of ANOVA for the ATU subjects of all racial groups, for the nine sub-scores of the SCL-90 and the total SCL-90 score (number of nonzero scores). There was a progressive decrease in the mean anxiety score from the LL, to SL to SS groups (P Ͻ 0.002) (Figure 2 ). By linear ANOVA P = 0.0005. Two other scores were significant at P Յ 0.05, phobic anxiety and total symptoms, but did not meet the more stringent criteria of Յ0.005. The Tukey test was positive for anxiety, phobic anxiety and total symptoms. To determine if the sample had adequate power, we used the formulas of Cohen 10 and the Power software program (Lawrence Erlbaum, Hillsdale, NJ, USA), an n of 179, ␣ = 0.05 effect size index of 0.71 (1.69 − 1.03/0.93), and three groups. This showed that the study had adequate power (1.0).
In a post hoc analysis we examined the magnitude of the SCL-90 anxiety score for all the alleles present more than 10 times. This showed that all the major long alleles (3, 4, 5 and 6) had SCL-90 anxiety scores of greater than 1.22 (range 1.22-1.60), and all the major short alleles (12, 13, 14, and 15) had SCL-90 anxiety scores of less than 1.18 (range 1.17-1.01). This supports the concept that the size of the alleles rather than their sequence can be the important variable for repeat polymorphisms.
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To examine the percent of the variance of these three scores accounted for by the ESR1 gene, the gene was scored on the basis of the ANOVA studies as LL = 2, SL = 1, and SS = 0. These results are shown in Table 2 . The ESR1 gene accounted for 7% of variance of the anxiety score (P Ն 0.0004), 5.4% of the total symptom score (P Յ 0.0039), and 3.9% of the phobic anxiety score (P Յ 0.0083). The anxiety and total symptoms score were significant at Յ0.005. When race was included as a covariant in the ANOVA for anxiety, the main effect of the ESR1 gene was significant at P Յ 0.002, while the effect of race was not significant P Յ 0.61. The present study was stimulated by our observation that the shorter alleles of the GGC and CAG repeat polymorphisms of the AR gene were significantly correlated with ADHD, conduct disorder and oppositional defiant disorder in subjects with Tourette syndrome. 3 In the brain, testosterone is converted by aromatase cytochrome P450 to estrogen. 12 Thus, a major effect of androgenic steroids is mediated via the estrogen receptor. This suggested we should also test genetic variants of the ESR1 gene for behavioral effects.
Since the SCL-90 is highly dependent upon subject's personality features and less correlated with clinicians' ratings, 13 the present results should be interpreted bearing this in mind. Thus, the correlations reported here could be with quantitative measures of anxiety, or with underlying personality traits. Replication studies using both the SCL-90 and cases of primary general anxiety disorder, panic disorder, or agoraphobia based on DSM-IV criteria and without comorbid substance abuse are desired. While requiring replication, the present results suggest that length variants at the dinucleotide repeat of the ESR1 gene do play a role in human behavior. Since this gene accounted for 7% of the variance of the SCL-90 anxiety score, this may be a candidate gene for anxiety. Since estrogen levels are much higher in females than in males, these results might explain the higher frequency of anxiety dis-orders in women. However, until studies indicating whether the L alleles are associated with an increase or decrease in estrogen receptor gene expression, more detailed speculation is impossible. Studies comparing the effect of the ESR1 gene on behavior in males vs females are needed.
Methods

Subjects
The subjects consisted of 179 male subjects from an inpatient Addiction Treatment Unit (ATU) of the Jerry L Pettis Veterans Administration Hospital in Loma Linda, California. Females were excluded because there were too few (three) for statistical significance. From 1994 to 1997, all new admissions to the ATU that give informed consent, were entered into a National Institute of Drug Abuse sponsored study of genetic factors in drug abuse/dependence. The study was approved by an IRB. They averaged 40.9 years of age (SD 6.91). Sixty-six percent were non-Hispanic Caucasians, 19% were African-American and 15% were Hispanic. All had a diagnosis of either alcohol dependence, drug dependence or both. Some had more than one type of substance dependence. Of these 125 were administered the Diagnostic Interview Schedule DSM-IIIR (DIS). 14 The following are the percentages of a range of DSM-IIIR substance dependence diagnoses based on the DIS: alcohol dependence 55%, amphetamine 29%, cannabis 23%, cocaine 27% and opioid 21%. Other diagnoses included pathological gambling 6%, somatiform disorder 24%, bipolar disorder 6%, dysthymia 16%, and panic disorder without agoraphobia 12%. Only one person had a diagnosis of general anxiety disorder.
The subjects were assessed for general psychiatric symptoms using the SCL-90 screening test. 9 All subjects were tested only after a period of at least 3 weeks had passed since detoxification and were otherwise drug free.
Genotyping
The dinucleotide repeat of the ESR1 gene described by del Senno was used. 8 The primers were 1 AGA CGC ATG ATA TAC TTC ACC and 2 GTT CAC TTG GGC TAG GAT AT. We used a different second primer than del Senno to allow multiplexing with several other genes on the ABI (Applied Biosystems, Foster City, CA, USA) DNA sequencer. This produced the same set of alleles described by del Senno except that ours were 21 bp longer. For PCR 400 nM of each primer and 50 ng of genomic DNA were added to Taq PCR Core Kit mixture (Qiagen, Chatsworth, CA, USA). The PCR conditions were 95°C for 30 s, 55°C for 1 min, 72°C for 1 min for 35 cycles. To label the PCR products, 0.1 M of each primer labeled with fluorescent HEX or FAM Amidite (Applied Biosystems) primers were used in the reactions. Two microliters of the 10-fold diluted PCR product were added to 2.5 l deionized formamide and 0.5 l of ROX 500 standard (Applied Biosystems) and denatured for 2 min at 92°C and loaded on 6% polyacrylamide gel in an Applied Biosystems 373 DNA sequencer. The gel was electrophoresed for 5 h at 1100 volts and constant 30 W. The gel was laser scanned and analyzed using the internal ROX 500 standards. The peaks were recognized by Genotyper (version 1.1) (Applied Biosystems) based on the color fragments sized by base pair length.
Scoring the ESR1 gene
Based on the published distribution of the ESR1 alleles 8 and our prior hypothesis that different lengths of the alleles of repeat polymorphisms play a direct role in gene regulation, 11 before we began any genotyping our a priori plan was to divide the ESR1 alleles into two groups, short (S) and long (L). The division would be arbitrarily made at the point that most precisely divided the alleles into two equal groups. This approach reduced the significant loss of power associated with examining each allele individually.
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Statistics ANOVA was used to examine the means of the nine SCL-90 subscores and total score. A post hoc Tukey test identified those means that were significantly different at ␣ Յ 0.05. To test for a linear trend the polynomial subcommand was set to 1. To examine the percent of the variance of the three most significant SCL-90 scores that were accounted for by the ESR1 gene, univariate regression analysis was used to determine r, r 2 , F and P of the correlation between the ESR1 gene score (see results) and the SCL-90 scores. The SPSS statistical package (SPSS, Chicago, IL, USA) was used. Since 10 scores were examined, a Bonferroni corrected ␣ of 0.05/10 or Յ0.005 was used as the most conservative assessment of significance.
